Article Details

Apalutamide Drives Ultra-Low PSA Levels in mCSPC - Targeted Oncology

Retrieved on: 2023-12-02 00:05:23

Tags for this article:

Click the tags to see associated articles and topics

Apalutamide Drives Ultra-Low PSA Levels in mCSPC - Targeted Oncology. View article details on hiswai:

Excerpt

That's an advantage that monoclonal antibodies have over small molecules, but because CBO421 is a biologic, it has both activities, so it results in ...

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo